glp 1 agonist lizard How a Canadian scientist and a venomous helped pave the way for Ozempic - National The system that turned Gila
Description
Over 30 years ago scientists discovered the potential of Gila monster venom as a treatment for type 2 diabetes.
Diabetic kidney disease, a common complication in patients with type 2 diabetes mellitus, is
Ozempic changed the conversation around weight loss in a way that almost nothing has in the past twenty years
More recent evidence is expanding their benefits to heart failure with preserved ejection fraction and clinically important renal outcomes in patients with and without diabetes
GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
